Explore Our Biomarker Menu

Biomarker:

VEGF-A

Biological or Clinical Significance:

Vascular endothelial growth factor A (VEGF-A) is a protein that in humans is encoded by the VEGFA gene. Vascular endothelial growth factor A (VEGF-A) is a dimeric glycoprotein that plays a significant role in neurons and is considered to be the main, dominant inducer to the growth of blood vessels. VEGFA is essential for adults during organ remodeling and diseases that involve blood vessels.

VEGF-A has been implicated with poor prognosis in breast cancer. VEGF-A is also released in rheumatoid arthritis in response to TNF-α, increasing endothelial permeability and swelling and also stimulating angiogenesis. VEGF-A is also important in diabetic retinopathy (DR). VEGF-A plays a role in the disease pathology of the wet form age-related macular degeneration (AMD), which is the leading cause of blindness for the elderly of the industrialized world. Once released, VEGF-A may elicit several responses. It may cause a cell to survive, move, or further differentiate. Hence, VEGF is a potential target for the treatment of cancer.

References:

Analyte:

VEGF-A

Matrix:

Human K2 EDTA Plasma

Status:

Validated

Sensitivity-LLOQ:

9.88 pg/mL

Sensitivity-ULOQ:

4,502 pg/mL

platform

Luminex, MSD-ECL

Required Sample Volume

50 µL/well

Disease State:

MSD Panel:

Cytokine Panel 1 (Human)

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.


    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.